Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    RAPT Therapeutics Inc.

    NASDAQ: RAPT · Real-Time Price · USD
    1.03
    -0.01 (-0.96%)
    At close: Jun 16, 2025, 3:59 PM
    1.11
    7.25%
    After-hours: Jun 16, 2025, 07:47 PM EDT

    RAPT Therapeutics Statistics

    Share Statistics

    RAPT Therapeutics has 132.29M shares outstanding. The number of shares has increased by 278.21% in one year.

    Shares Outstanding

    n/a
    		 132.29M

    Shares Change (YoY)

    n/a
    		 278.21%

    Shares Change (QoQ)

    n/a
    		 277.61%

    Owned by Institutions (%)

    n/a
    		 99.99%

    Shares Floating

    n/a
    		 68.99M

    Failed to Deliver (FTD) Shares

    n/a
    		 9

    FTD / Avg. Volume

    n/a
    		 n/a

    Short Selling Information

    The latest short interest is 6.01M, so 4.54% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 6.01M

    Short % of Shares Out

    n/a
    		 4.54%

    Short % of Float

    n/a
    		 5.5%

    Short Ratio (days to cover)

    n/a
    		 4.69

    Valuation Ratios

    The PE ratio is -0.5 and the forward PE ratio is -2.1. RAPT Therapeutics's PEG ratio is -0.11.

    PE Ratio

    n/a
    		 -0.5

    Forward PE

    n/a
    		 -2.1

    PS Ratio

    n/a
    		 0

    Forward PS

    n/a
    		 7.5

    PB Ratio

    n/a
    		 0.34

    P/FCF Ratio

    n/a
    		 -0.77

    PEG Ratio

    n/a
    		 -0.11
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for RAPT Therapeutics.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 4.87, with a Debt / Equity ratio of 0.02.

    Current Ratio

    n/a
    		 4.87

    Quick Ratio

    n/a
    		 4.87

    Debt / Equity

    n/a
    		 0.02

    Debt / EBITDA

    n/a
    		 -0.04

    Debt / FCF

    n/a
    		 -0.05

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 n/a

    Profits Per Employee

    n/a
    		 $-1,938,283.58

    Employee Count

    n/a
    		 67

    Asset Turnover

    n/a
    		 0

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 n/a

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by -68.88% in the last 52 weeks. The beta is -0.14, so RAPT Therapeutics's price volatility has been lower than the market average.

    Beta

    n/a
    		 -0.14

    52-Week Price Change

    n/a
    		 -68.88%

    50-Day Moving Average

    n/a
    		 0.93

    200-Day Moving Average

    n/a
    		 1.35

    Relative Strength Index (RSI)

    n/a
    		 51.47

    Average Volume (20 Days)

    n/a
    		 937,471

    Income Statement

    Revenue

    n/a
    		 n/a

    Gross Profit

    n/a
    		 n/a

    Operating Income

    n/a
    		 -136.1M

    Net Income

    n/a
    		 -129.87M

    EBITDA

    n/a
    		 -126.33M

    EBIT

    n/a
    		 -129.87M

    Earnings Per Share (EPS)

    n/a
    		 -3.19
    Full Income Statement

    Balance Sheet

    The company has 169.74M in cash and 4.49M in debt, giving a net cash position of 165.24M.

    Cash & Cash Equivalents

    n/a
    		 169.74M

    Total Debt

    n/a
    		 4.49M

    Net Cash

    n/a
    		 165.24M

    Retained Earnings

    n/a
    		 -614.55M

    Total Assets

    n/a
    		 187.57M

    Working Capital

    n/a
    		 174.52M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -83.3M and capital expenditures -122K, giving a free cash flow of -83.42M.

    Operating Cash Flow

    n/a
    		 -83.3M

    Capital Expenditures

    n/a
    		 -122K

    Free Cash Flow

    n/a
    		 -83.42M

    FCF Per Share

    n/a
    		 -2.05
    Full Cash Flow Statement

    Margins

    Gross Margin

    n/a
    		 n/a

    Operating Margin

    n/a
    		 n/a

    Pretax Margin

    n/a
    		 n/a

    Profit Margin

    n/a
    		 n/a

    EBITDA Margin

    n/a
    		 n/a

    EBIT Margin

    n/a
    		 n/a

    FCF Margin

    n/a
    		 n/a

    Dividends & Yields

    RAPT does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for RAPT is $32, which is 3006.8% higher than the current price. The consensus rating is "Hold".

    Price Target

    n/a
    		 $32

    Price Target Difference

    n/a
    		 3006.8%

    Analyst Consensus

    n/a
    		 Hold

    Analyst Count

    n/a
    		 4
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on Jun 17, 2025. It was a backward split with a ratio of 1:8.

    Last Split Date

    n/a
    		 Jun 17, 2025

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:8

    Scores

    Altman Z-Score

    n/a
    		 1.48

    Piotroski F-Score

    n/a
    		 2

    Add to Watchlist